arotinolol has been researched along with Atherosclerotic Parkinsonism in 1 studies
arotinolol: structure given in first source; arotinolol is the (+-)-isomer
Excerpt | Relevance | Reference |
---|---|---|
"The effect of arotinolol, a peripherally acting beta-adrenergic-blocking agent, on postural or kinetic tremor was studied in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism." | 7.68 | Therapeutic effects of arotinolol, a beta-adrenergic blocker, on tremor in MPTP-induced parkinsonian monkeys. ( Kuno, S; Mizuta, E; Nishida, J; Takechi, M, 1992) |
"The effect of arotinolol, a peripherally acting beta-adrenergic-blocking agent, on postural or kinetic tremor was studied in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism." | 3.68 | Therapeutic effects of arotinolol, a beta-adrenergic blocker, on tremor in MPTP-induced parkinsonian monkeys. ( Kuno, S; Mizuta, E; Nishida, J; Takechi, M, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kuno, S | 1 |
Mizuta, E | 1 |
Nishida, J | 1 |
Takechi, M | 1 |
1 other study available for arotinolol and Atherosclerotic Parkinsonism
Article | Year |
---|---|
Therapeutic effects of arotinolol, a beta-adrenergic blocker, on tremor in MPTP-induced parkinsonian monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic beta-Antagonists; Animals; Macaca fascicula | 1992 |